Novavax said the trials would test ‘the efficacy and safety’ of the vaccine, with participants receiving either the vaccine candidate or placebo in two doses.
Novavax said the trials would test ‘the efficacy and safety’ of the vaccine, with participants receiving either the vaccine candidate or placebo in two doses.
Follow Us
© 2022 PBC News